Schulhoff & Co. Inc. lessened its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 8.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,680 shares of the medical technology company’s stock after selling 520 shares during the quarter. Schulhoff & Co. Inc.’s holdings in Hill-Rom were worth $502,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Oakbrook Investments LLC raised its position in Hill-Rom by 34.5% during the third quarter. Oakbrook Investments LLC now owns 8,967 shares of the medical technology company’s stock worth $846,000 after acquiring an additional 2,300 shares in the last quarter. LSV Asset Management bought a new stake in Hill-Rom during the third quarter worth $715,000. Vanguard Group Inc raised its position in Hill-Rom by 0.6% during the third quarter. Vanguard Group Inc now owns 5,916,827 shares of the medical technology company’s stock worth $558,549,000 after acquiring an additional 34,369 shares in the last quarter. TIAA CREF Investment Management LLC raised its position in Hill-Rom by 2.1% during the third quarter. TIAA CREF Investment Management LLC now owns 192,606 shares of the medical technology company’s stock worth $18,182,000 after acquiring an additional 4,010 shares in the last quarter. Finally, Virtu Financial LLC bought a new stake in Hill-Rom during the fourth quarter worth $299,000. 86.96% of the stock is currently owned by institutional investors and hedge funds.

Several analysts have issued reports on HRC shares. Zacks Investment Research lowered shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Wednesday, November 14th. Morgan Stanley dropped their price target on shares of Hill-Rom from $100.00 to $98.00 and set an “equal weight” rating on the stock in a research report on Wednesday, January 2nd. Finally, ValuEngine lowered shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Wednesday, January 2nd. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $102.67.

In other news, SVP Andreas G. Frank sold 7,454 shares of the stock in a transaction dated Wednesday, November 28th. The shares were sold at an average price of $95.76, for a total value of $713,795.04. Following the transaction, the senior vice president now directly owns 27,224 shares of the company’s stock, valued at $2,606,970.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.73% of the stock is owned by corporate insiders.

Shares of HRC traded up $1.04 during trading hours on Monday, hitting $104.61. The company had a trading volume of 554,155 shares, compared to its average volume of 570,253. The firm has a market capitalization of $6.97 billion, a PE ratio of 22.02, a PEG ratio of 1.46 and a beta of 0.95. Hill-Rom Holdings, Inc. has a 12 month low of $80.70 and a 12 month high of $105.78. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.70 and a quick ratio of 1.25.

Hill-Rom (NYSE:HRC) last issued its quarterly earnings data on Friday, January 25th. The medical technology company reported $1.02 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.98 by $0.04. The company had revenue of $683.50 million for the quarter, compared to analyst estimates of $676.39 million. Hill-Rom had a net margin of 7.21% and a return on equity of 21.23%. The company’s revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.92 earnings per share. Analysts predict that Hill-Rom Holdings, Inc. will post 5.06 earnings per share for the current fiscal year.

WARNING: “Schulhoff & Co. Inc. Cuts Stake in Hill-Rom Holdings, Inc. (HRC)” was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another publication, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://theolympiareport.com/2019/02/18/schulhoff-co-inc-cuts-stake-in-hill-rom-holdings-inc-hrc.html.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Featured Story: What is a stock split?

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.